REPLICEL LIFE SCIENCES INC.
VANCOUVER BC, A1 · CIK 0001205059 · Biotech · Public
Autologous cell therapies for regenerative medicine applications
replicel.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $5.8M
- 23 Form D · Dec 2024
- 22 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 15
- 5 granted · 10 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20112013201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $272,998 | |
| Private capital raised | Form D · SEC | $594,050 | |
| Private capital raised | Form D · SEC | $245 | |
| Private capital raised | Form D · SEC | $70,210 | |
| Private capital raised | Form D · SEC | $143,033 | |
| Private capital raised | Form D · SEC | $112,274 | |
| Private capital raised | Form D · SEC | $8,536 | |
| Private capital raised | Form D · SEC | $267,158 | |
| Private capital raised | Form D · SEC | $20,883 | |
| Private capital raised | Form D · SEC | $76,030 | |
| Private capital raised | Form D · SEC | $135,078 | |
| Private capital raised | Form D · SEC | $447,064 | |
| Private capital raised | Form D · SEC | $118,181 | |
| Private capital raised | Form D · SEC | $385,848 | |
| Private capital raised | Form D · SEC | $9,012 | |
| Private capital raised | Form D · SEC | $111,574 | |
| Private capital raised | Form D · SEC | $777,659 | |
| Private capital raised | Form D · SEC | $592,728 | |
| Private capital raised | Form D · SEC | $558,837 | |
| Private capital raised | Form D · SEC | $86,942 | |
| Private capital raised | Form D · SEC | $9,196 | |
| Private capital raised | Form D · SEC | $740,778 | |
| Private capital raised | Form D · SEC | $223,665 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1512 | BIOLOGICAL ANTI-INFECTIVE MEDICINES, LLC | — | — |
| 1513 | SYNCANICA BIO | — | — |
| 1514 | Juvenescence | — | $115M |
| 1515 | REPLICEL LIFE SCIENCES INC. | — | $5.8M |
| 1516 | Ideaya Biosciences, Inc. | — | $111M |
| 1517 | Virscio Inc | — | — |
| 1518 | Moonwalk Biosciences | — | $110M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Ben AustringExecutive Officer
- BEN AUSTRINGExecutive Officer
- Gary BoddingtonDirector
- GARY BODDINGTONDirector
- Lee BucklerDirector
- LEE BUCKLERDirector · Executive Officer
- JOHN CHALLISDirector
- David HallDirector · Executive Officer
- DAVID HALLDirector · Executive Officer
- ROLF HOFFMANDirector · Executive Officer
- ROLF HOFFMANNExecutive Officer
- LARISSA HUANGDirector
- PETER JENSENDirector · Executive Officer
- TOM KORDYBACKExecutive Officer
- David KwokExecutive Officer
- Peter LewisDirector
- PETER LEWISDirector
- PETER LOWRYDirector
- SIMON MAExecutive Officer
- Jamie MackayDirector
- GEOFF MACKAYDirector
- Kevin McElweeExecutive Officer
- KEVIN MCELWEEExecutive Officer
- HUGH ROGERSPromoter
- Andrew SchutteDirector · Executive Officer
- ANDREW SCHUTTEDirector · Executive Officer
- GAVIN YEDirector
Patents
- Injection Devicesapplication
- Injection Devicesgranted
- Injection Devicesgranted
- Injection Devicesgranted
- Compositions And Methods For Treating Skinapplication
- Compositions And Methods For Treating And Repairing Tendonsapplication
- Compositions And Methods For Treating Bone, Joints And Cartilagegranted
- Compositions And Methods For Treating And Repairing Tendonsgranted
- Compositions And Methods Relating To Treatments Of The Oral Cavityapplication
- Compositions And Methods For Treating Skinapplication
- Injection Devicesapplication
- Injection Devicesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.